PL410186A1 - Method, application and a set for detecting high risk breast cancer with bad prognosis - Google Patents

Method, application and a set for detecting high risk breast cancer with bad prognosis

Info

Publication number
PL410186A1
PL410186A1 PL410186A PL41018614A PL410186A1 PL 410186 A1 PL410186 A1 PL 410186A1 PL 410186 A PL410186 A PL 410186A PL 41018614 A PL41018614 A PL 41018614A PL 410186 A1 PL410186 A1 PL 410186A1
Authority
PL
Poland
Prior art keywords
breast cancer
application
high risk
detecting high
bad prognosis
Prior art date
Application number
PL410186A
Other languages
Polish (pl)
Other versions
PL236572B1 (en
Inventor
Cezary Cybulski
Jan Lubiński
Original Assignee
Pomorski Uniwersytet Medyczny W Szczecinie
Cezary Cybulski
Jan Lubiński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomorski Uniwersytet Medyczny W Szczecinie, Cezary Cybulski, Jan Lubiński filed Critical Pomorski Uniwersytet Medyczny W Szczecinie
Priority to PL410186A priority Critical patent/PL236572B1/en
Publication of PL410186A1 publication Critical patent/PL410186A1/en
Publication of PL236572B1 publication Critical patent/PL236572B1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Wynalazek ujawnia sposoby i produkty znajdujące zastosowanie w diagnozowaniu genetycznej predyspozycji do chorób u ludzi i polega na ocenie czy w materiale biologicznym badanej osoby występuje specyficzna zmiana konstytucyjna w genie PALB2. Wynalazek dotyczy nowej metody diagnostycznej wykrywającej wysoką genetyczną predyspozycję do inwazyjnego raka piersi o złym rokowaniu. Sposób i zestaw diagnostyczny dotyczy opracowania nowego markera złego rokowania dla raka piersi.The invention discloses methods and products used in the diagnosis of genetic predisposition to human diseases and consists in assessing whether a specific constitutional change in the PALB2 gene occurs in the biological material of the examined person. The invention relates to a new diagnostic method detecting a high genetic predisposition to invasive breast cancer with poor prognosis. The method and diagnostic kit concerns the development of a new marker of poor prognosis for breast cancer.

PL410186A 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis PL236572B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Publications (2)

Publication Number Publication Date
PL410186A1 true PL410186A1 (en) 2016-05-23
PL236572B1 PL236572B1 (en) 2021-01-25

Family

ID=55970673

Family Applications (1)

Application Number Title Priority Date Filing Date
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Country Status (1)

Country Link
PL (1) PL236572B1 (en)

Also Published As

Publication number Publication date
PL236572B1 (en) 2021-01-25

Similar Documents

Publication Publication Date Title
BR112015023120A2 (en) method for identifying an individual with a disease or dysfunction, method for predicting the responsiveness of an individual with a disease or dysfunction, method for determining the likelihood that an individual with a disease or dysfunction will exhibit benefit from treatment, method for selecting a therapy, Uses of a pd-11 Axis Binding Antagonist, Assay to Identify an Individual with a Disease, Diagnostic Kit, Method to Evaluate a Treatment Response, and Method to Monitor the Response of a Treated Individual
MX2020001156A (en) METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS.
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
MX2015006757A (en) METHOD FOR EVALUATING THE PRESENCE OF OR RISK OF COLUM TUMORS.
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
WO2014028884A3 (en) Cancer diagnostics using biomarkers
NZ607282A (en) Method for using gene expression to determine prognosis of prostate cancer
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
JP2014144959A5 (en)
BR112014031414A2 (en) methods of detecting disease or conditions using circulating diseased cells
MX2011012913A (en) Methods for breast cancer risk assessment.
HK1197085A1 (en) Genetic variants for predicting risk of breast cancer
EA201370063A1 (en) PHOSPHOLYPIDE CANCER
MX392267B (en) METHODS FOR EVALUATING THE RISK OF DEVELOPING BREAST CANCER.
SG11201811263WA (en) Molecular marker, reference gene, and application and test kit thereof, and method for constructing testing model
MY179845A (en) Specific biomarker set for non-invasive diagnosis of liver cancer
MX2012007009A (en) METHOD FOR DIAGNOSING A MALIGNOUS TUMOR.
MX2019008005A (en) Methods and compositions for diagnosing preeclampsia.
MA40636A (en) METHODS TO DETECT PROSTATE CANCER
MX384485B (en) EARLY DETECTION OF PREECLAMPSIA.
Renfro et al. Center-within-trial versus trial-level evaluation of surrogate endpoints
WO2013188823A3 (en) Cancer prognostic assays
PL401271A1 (en) Method and kit for the detection of aggressive prostate cancer with poor prognosis
PL411632A1 (en) Method, application and a set for detecting high risk breast cancer by examination of RECQL gene mutations